This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laurent, S. Articles by Schmitt, H. Search for Related Content PubMed PubMed Citation Articles by Laurent, S. Articles by Schmitt, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Hypertension, Vol 9, 132-138, Copyright © 1987 by American Heart Association

ARTICLES

Opposite central cardiovascular effects of nifedipine and BAY k 8644 in anesthetized rats

S Laurent, X Girerd, D Tsoukaris-Kupfer, M Legrand, AM Huchet-Brisac and H Schmitt

The central cardiovascular effects of the calcium channel blocker nifedipine and the calcium channel activator BAY k 8644 were studied in anesthetized and ventilated normotensive Wistar-Kyoto (WKY) or spontaneously hypertensive rats (SHR). Both drugs were administered in a 1.5-microliter volume into the lateral ventricle of the brain (i.c.v.) or into the cisterna magna (i.c.). The injection of vehicle alone (i.c. or i.c.v.) did not significantly change mean arterial pressure (MAP) or heart rate. Nifedipine (5 and 50 micrograms/kg) and BAY k 8644 (5 and 50 micrograms/kg) induced opposite effects on MAP when centrally injected. Nifedipine decreased MAP and induced a bradycardia (i.c.v.) or no change in heart rate (i.c.), and BAY k 8644 increased MAP without any significant change in heart rate (i.c. or i.c.v.). These effects were more marked with the highest dose of either drug. These effects seemed to be of central origin, since they were suppressed by ganglionic blockade by hexamethonium (100 mg/kg i.v.), whereas after hexamethonium the hypotensive and the hypertensive responses to intravenously injected nifedipine and BAY k 8644, respectively, were preserved. Bilateral vagotomy suppressed the bradycardia induced by i.c.v. administered nifedipine. Previously i.c.v. administered nifedipine (5 micrograms/kg) antagonized the pressor response to BAY k 8644 (5 micrograms/kg i.c.v.). Changes in MAP and heart rate were significantly more marked in SHR than in WKY. These results indicate that a calcium channel inhibitor and a calcium channel activator can modulate in opposite fashion central mechanisms involved in blood pressure control.

This article has been cited by other articles:

				P. Busquet, A. Hetzenauer, M. J. Sinnegger-Brauns, J. Striessnig, and N. Singewald Role of L-type Ca2+ channel isoforms in the extinction of conditioned fear Learn. Mem., April 25, 2008; 15(5): 378 - 386. [Abstract] [Full Text] [PDF]

				B. S. Huang and F. H. H. Leenen Sympathoinhibitory Effects of Central Nifedipine in Spontaneously Hypertensive Rats on High Versus Regular Sodium Intake Hypertension, January 1, 1999; 33(1): 32 - 35. [Abstract] [Full Text] [PDF]

				M. Uechi, K. Asai, N. Sato, and S. F. Vatner Voltage-Dependent Calcium Channel Promoter Restores Baroreflex Sensitivity in Conscious Dogs With Heart Failure Circulation, September 29, 1998; 98(13): 1342 - 1347. [Abstract] [Full Text] [PDF]

				R. Venuto, G. Brown, M. Schoenl, and G. Losonczy Enhanced vascular effects of the Ca2+ channel agonist Bay K 8644 in pregnant rabbits Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R952 - R959. [Abstract] [Full Text] [PDF]